Both in Pharmaceuticals
Neurogene vs Shattuck Labs
Over the past year NGNE returned −13.3% and STTK returned +166.8%; their daily moves had a correlation of 0.20.
NGNE −13.3% STTK +166.8%Growth of $1, one year, split-adjusted
| Metric | NGNE | STTK |
|---|---|---|
| Price | $27.58 | $5.15 |
| Market cap | $551.9M | $516.9M |
| Today | +3.41% | −5.85% |
| 1 month | +8.4% | −12.1% |
| 6 months | −14.7% | −22.9% |
| Year to date | +33.9% | +41.1% |
| 1 year | −11.2% | +158.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 516.9× |
| Net cash | $225.4M | $208.3M |
| Dividend yield | — | — |
| Volatility (60d) | 76.6% | 59.6% |
| Short % of float | 39.6% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).